Back to SYRE
Assenagon Asset Management S.A. → SYRE
Assenagon Asset Management S.A. SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$53.3M
Q3 2026
Peak value
$53.3M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $371K |
| Q4 2025 | $725K |
| Q1 2026 | $941K |
| Q3 2026 | $53.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $53.3M | 599.2K | — | — |
| Q1 2026 | $941K | 18.6K | — | — |
| Q4 2025 | $725K | 22.1K | — | — |
| Q3 2025 | $371K | 22.1K | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$348.1M
$336.7M
$318.8M